43rd Annual J.P. Morgan Healthcare Conference

As the market-leading commercialization partner, we are positioned at the forefront of innovation, and we are committed to being at the heart of healthcare’s next wave of breakthroughs to ensure the right treatments get to the right patients, faster.

We partner with biotech companies, emerging and established, to maximize value at every stage of the commercialization journey. Our experience spans from early-stage research to global market success, supporting proprietary drugs in all therapeutic areas.

Our experts will be on the ground at the JP Morgan Healthcare Conference in San Francisco, from January 13 – 16, to connect with the industry’s most innovative minds, explore cutting-edge technologies, and contribute to the development of life-changing treatments.

From early-stage research to global market launch, we provide tailored solutions that:

• Accelerate innovation: Over 60% of our work is driven by data, GenAI & technology, accelerating your drug development and commercialization process. Our advanced analytics can optimize clinical trials, identify new opportunities, and speed up time-to-market.
• Maximize value and minimize risk: Unlock the full potential of your assets through strategic guidance, unparalleled therapeutic expertise, and innovative strategies to mitigate challenges and optimize decision-making.
• Enhance patient access: We work with biotech to expedite the development and delivery of life-saving therapies to patients who need them – learn more about how we partnered with our client to raise the profile of a novel Alzheimer’s drug here.

Heading to the 43rd Annual J.P. Morgan Healthcare Conference? Book a meeting with our experts now.